Safety and efficacy of nanofiltered C1 esterase inhibitor (human) for the treatment of laryngeal attacks in subjects with hereditary angioedema

被引:0
|
作者
Riedl, M.
Baker, J.
Hurewitz, D.
Lumry, W.
Vegh, A.
White, M.
Grant, A.
Busse, P.
Mariano, D.
Kalfus, I
Rubinstein, A.
Broom, C.
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
1093
引用
收藏
页码:420 / 420
页数:1
相关论文
共 50 条
  • [1] Safety and Efficacy of Nanofiltered C1 Esterase Inhibitor (Human) (Cinryze™) for the Treatment of Laryngeal Attacks in Subjects with Hereditary Angioedema (HAE)
    Riedl, M.
    Baker, J.
    Hurewitz, D.
    Lumry, W. R.
    Vegh, A.
    White, M.
    Grant, J. A.
    Busse, P.
    Rubinstein, A.
    Kalfus, I.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB233 - AB233
  • [2] Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema
    Riedl, Marc A.
    Lumry, William R.
    Li, H. Henry
    Craig, Timothy J.
    Fitts, David
    Kalfus, Ira
    Uknis, Marc E.
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2013, 27 (06) : 517 - 521
  • [3] Use of nanofiltered C1 esterase inhibitor (human) for the treatment of gastrointestinal attacks in subjects with hereditary angioedema
    Lumry, W.
    Baker, J.
    Levy, R.
    Hurewitz, D.
    White, M.
    Craig, T.
    Riedl, M.
    Busse, P.
    Grant, A.
    Mariano, D.
    Kalfus, I
    ALLERGY, 2011, 66 : 418 - 419
  • [4] Use of nanofiltered C1 esterase inhibitor (human) for the treatment of extremity and facial attacks in subjects with hereditary angioedema
    Riedl, M.
    Lumry, W.
    Baker, J.
    Levy, R.
    Hurewitz, D.
    White, M.
    Craig, T.
    Busse, P.
    Grant, A.
    Tillotson, G.
    Kalfus, I
    Mariano, D.
    ALLERGY, 2011, 66 : 421 - 421
  • [5] Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women
    Baker, James W.
    Craig, Timothy J.
    Riedl, Marc A.
    Banerji, Aleena
    Fitts, David
    Kalfus, Ira N.
    Uknis, Marc E.
    ALLERGY AND ASTHMA PROCEEDINGS, 2013, 34 (02) : 162 - 169
  • [6] Open-label use of nanofiltered C1 esterase inhibitor (human) for the treatment of hereditary angioedema attacks
    Riedl, M.
    Zuraw, B.
    Lumry, W.
    Baker, J.
    Levy, R.
    Hurewitz, D.
    White, M.
    Craig, T.
    Busse, P.
    Bielory, L.
    Grant, A.
    Tillotson, G.
    Kalfus, I
    ALLERGY, 2011, 66 : 422 - 423
  • [7] Open-label use of nanofiltered C1 esterase inhibitor (human) for treatment of acute attacks of hereditary angioedema in pediatric subjects
    Lumry, W.
    Davis-Lorton, M.
    Manning, M.
    Craig, T.
    Tillotson, G.
    Kalfus, I
    Baker, J.
    ALLERGY, 2011, 66 : 418 - 418
  • [8] Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks
    Grant, J. Andrew
    White, Martha V.
    Li, H. Henry
    Fitts, David
    Kalfus, Ira N.
    Uknis, Marc E.
    Lumry, William R.
    ALLERGY AND ASTHMA PROCEEDINGS, 2012, 33 (04) : 348 - 353
  • [9] Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial
    Riedl, Marc A.
    Hurewitz, David S.
    Levy, Robyn
    Busse, Paula J.
    Fitts, David
    Kalfus, Ira
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 108 (01) : 49 - 53
  • [10] Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacks
    Li, H. Henry
    Reshef, Avner
    Baker, James W.
    Harper, Joseph R.
    Relan, Anurag
    ALLERGY AND ASTHMA PROCEEDINGS, 2017, 38 (06) : 456 - 461